These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1019196)

  • 1. [Injection molding of oral retard preparations. Part 6. Variations in outer surface geometry].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1976; 31(10):724-8. PubMed ID: 1019196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Injection molding of preoral sustained-release preparations. 5. Development of a solid foam body].
    Schmeiss U; Hüttenrauch R
    Pharmazie; 1976 Aug; 31(8):559-62. PubMed ID: 996077
    [No Abstract]   [Full Text] [Related]  

  • 3. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Injection-molding technic for the production of oral delayed action preparations. 1. Injection molding].
    Hüttenrauch R
    Pharmazie; 1974 May; 29(5):297-302. PubMed ID: 4603635
    [No Abstract]   [Full Text] [Related]  

  • 5. IVIVC of controlled release formulations: physiological-dynamical reasons for their failure.
    Dokoumetzidis A; Macheras P
    J Control Release; 2008 Jul; 129(2):76-8. PubMed ID: 18538435
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2007 Nov; 32(3):231-9. PubMed ID: 17889515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Injection casting procedure for the preparation of oral delayed-action preparations. 4. Break-in of channeling pharmaceutic aids].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1976 Jul; 31(7):471-4. PubMed ID: 981302
    [No Abstract]   [Full Text] [Related]  

  • 8. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 9. Roll compaction/dry granulation: pharmaceutical applications.
    Kleinebudde P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Injection molding technic for the production of oral retard preparations. 2. Structure of the matrix].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Apr; 30(4):229-33. PubMed ID: 1153488
    [No Abstract]   [Full Text] [Related]  

  • 14. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
    Xu X; Chen X; Ma P; Wang X; Jing X
    Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of the solubility of drugs on their liberation from polymethacrylate-coated retard pellets].
    Hennig D; Kala H
    Pharmazie; 1986 Nov; 41(11):814-5. PubMed ID: 3562516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of nano-fibrous collagen microspheres for protein delivery and effects of photochemical crosslinking on release kinetics.
    Chan OC; So KF; Chan BP
    J Control Release; 2008 Jul; 129(2):135-43. PubMed ID: 18514352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.